Drug Combo Lowers Death Risk in Advanced Prostate Cancer by 40%

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier. Pairing enzalutamide with leuprolide cut the risk of death by more than 40% compared to standard therapy.

The 7 Best Medicare Advantage Plans: What to know before you enroll Choosing the right plan can be confusing. Here are the top-rated plans for 2025, what's changing for 2026, and how to find the coverage that fits your needs. October 21, 2025   TODAY'S TOP STORY Drug Combo Lowers Death Risk in Advanced Prostate Cancer by 40% READ ON   Drugstore Nasal Spray May Cut COVID-19 Risk by 69%, Cold Risk by 71% READ ON   U.S. Measles Cases Hit 33-Year High: How to Protect Yourself During the Outbreak READ ON   Head Twitching READ ON MORE STORIES   Sponsored   TODAY'S RESOURCE Find Connection, Answers, and Inspiration with Bezzy MS   Join Bezzy MS to connect with people who get it — because they're living with MS too. JOIN NOW What we're reading next • What Is Aerophagia and How Is It Treated? • What to Know (and Do) About Ulcerative Colitis Flare-Ups • Understanding Medicare Part D Eligibility • Does Protein Powder Expire? FOLLOW US ON INSTAGRAM We'd love to hear from you! Send us a message at newsletters@healthline.com to let us know what else you'd like to see. Until then, Take care of yourself, and we'll see you again soon! View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy   |   Unsubscribe We may feature your messages to our inbox within our content. Please do not provide any personal identifiable information. Replies may be edited for length and clarity. For more, see our Privacy Policy. Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional. Every product we recommend has gone through either Healthline's or Optum Now's vetting processes. If you buy through links on this page, we may receive a small commission or other tangible benefit. Healthline has sole editorial control over this newsletter. Potential uses for the products listed here are not health claims made by the manufacturers. Healthline and Optum Now are owned by RVO Health. © 2025 RVO Health 1101 Red Ventures Drive Fort Mill, SC 29707